Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Short-term Investments (2016 - 2017)

Northwest Biotherapeutics (NWBO) has 4 years of Short-term Investments data on record, last reported at $397000.0 in Q1 2017.

  • For Q1 2017, Short-term Investments fell 46.78% year-over-year to $397000.0; the TTM value through Mar 2017 reached $397000.0, down 46.78%, while the annual FY2016 figure was $685000.0, 22.69% down from the prior year.
  • Short-term Investments reached $397000.0 in Q1 2017 per NWBO's latest filing, down from $685000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.0 million in Q2 2015 and bottomed at $397000.0 in Q1 2017.
  • Average Short-term Investments over 4 years is $779400.0, with a median of $806000.0 recorded in 2014.
  • Peak YoY movement for Short-term Investments: rose 2.43% in 2015, then crashed 46.78% in 2017.
  • A 4-year view of Short-term Investments shows it stood at $865000.0 in 2014, then rose by 2.43% to $886000.0 in 2015, then fell by 22.69% to $685000.0 in 2016, then crashed by 42.04% to $397000.0 in 2017.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $397000.0 in Q1 2017, $685000.0 in Q4 2016, and $685000.0 in Q3 2016.